Barclays analyst Gena Wang maintained a Buy rating on Legend Biotech (LEGN – Research Report) today and set a price target of $94.00. The company’s shares closed last Friday at $36.91.

"Both the change of name, and outstanding share reduction initiatives mark significant steps forward for the development of Ventana Global, Inc," stated Stephen Replin, President and CEO of the ...

Jan. 23, 2025 — Researchers have uncovered which genes on the Y chromosome regulate the development of sperm and impact fertility in male mice. This research could help us understand why some ...

EU targets AI, biotech, green tech, advance materials sectors Draghi report said EU is falling behind US and China France, Trump push EU to cut business red tape EU plans include 25% reduction of ...

The BioXplorer 100 from H.E.L is a multi-bioreactor system that has been specifically developed for the optimization of aerobic fermentations. Having a working volume as low as 50 mL, the ...

4D Molecular Therapeutics Inc. 1.29% $218.19M ...

IPC Indice de Precios Y Cotizaciones 51,535.96-151.49-0.29% ...

After hours: January 27 at 6:12:18 PM EST Loading Chart for VIR ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...